Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 19;15(16):3640.
doi: 10.3390/nu15163640.

Nutritional Support for Liver Diseases

Dominika Jamioł-Milc  1 , Anna Gudan  1 , Karolina Kaźmierczak-Siedlecka  2 , Joanna Hołowko-Ziółek  1 , Dominika Maciejewska-Markiewicz  1 , Katarzyna Janda-Milczarek  1 , Ewa Stachowska  1
Affiliations
Review

Nutritional Support for Liver Diseases

Dominika Jamioł-Milc et al. Nutrients. .

Abstract

The liver is a key organ that is responsible for the metabolism of proteins, fats, and carbohydrates and the absorption and storage of micronutrients. Unfortunately, the prevalence of chronic liver diseases at various stages of advancement in the world population is significant. Due to the physiological function of the liver, its dysfunction can lead to malnutrition and sarcopenia, and the patient's nutritional status is an important prognostic factor. This review discusses key issues related to the diet therapy of patients with chronic liver diseases, as well as those qualified for liver transplantation and in the postoperative period.

Keywords: NAFLD; NASH; cholangiocarcinoma; cirrhosis; liver diseases; liver transplantation; nutrition.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The effects of omega-3 fatty acids intake in NAFLD patients (BMI—body mass index; FFA—free fatty acids; HDL—high-density lipoprotein; non-HDL—non-high-density lipoprotein; TC—total cholesterol; TG—triacyloglicerydes. (Created with BioRender.com).
Figure 2
Figure 2
Causes and effects of malnutrition and sarcopenia in a patient with cirrhosis. (Created with BioRender.com).
See this image and copyright information in PMC

References

    1. Sharma A., Nagalli S. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2023. Chronic Liver Disease. - PubMed
    1. Cheung K., Lee S.S., Raman M. Prevalence and Mechanisms of Malnutrition in Patients with Advanced Liver Disease, and Nutrition Management Strategies. Clin. Gastroenterol. Hepatol. 2012;10:117–125. doi: 10.1016/j.cgh.2011.08.016. - DOI - PubMed
    1. Younossi Z., Tacke F., Arrese M., Chander Sharma B., Mostafa I., Bugianesi E., Wai-Sun Wong V., Yilmaz Y., George J., Fan J., et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 2019;69:2672–2682. doi: 10.1002/hep.30251. - DOI - PubMed
    1. Shergill R., Syed W., Rizvi S.A., Singh I. Nutritional Support in Chronic Liver Disease and Cirrhotics. World J. Hepatol. 2018;10:685–694. doi: 10.4254/wjh.v10.i10.685. - DOI - PMC - PubMed
    1. Bischoff S.C., Bernal W., Dasarathy S., Merli M., Plank L.D., Schütz T., Plauth M. ESPEN Practical Guideline: Clinical Nutrition in Liver Disease. Clin. Nutr. 2020;39:3533–3562. doi: 10.1016/j.clnu.2020.09.001. - DOI - PubMed